Trial
NCT04757571
The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sadat City University
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
Paroxetine
Why stopped
Institutional and funding constrains
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-14